DrugPatentWatch Database Preview
BINOSTO Drug Profile
Which patents cover Binosto, and when can generic versions of Binosto launch?
Binosto is a drug marketed by Mission Pharma and is included in one NDA. There are two patents protecting this drug.
This drug has eleven patent family members in seven countries.
The generic ingredient in BINOSTO is alendronate sodium. There are twenty-five drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.
Summary for BINOSTO
| International Patents: | 11 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 33 |
| Clinical Trials: | 1 |
| Patent Applications: | 22 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for BINOSTO |
| Prior Art and Litigation Support | Order Prior Art and Litigation support for BINOSTO |
| DailyMed Link: | BINOSTO at DailyMed |
Pharmacology for BINOSTO
| Drug Class | Bisphosphonate |
Medical Subject Heading (MeSH) Categories for BINOSTO
Synonyms for BINOSTO
| (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonic Acid Monosodium Salt |
| (4-Amino-1-hydroxybutylidene)bisphosphonic acid monosodium salt |
| 129318-43-0 |
| 4-Amino-1-hydroxybutylidine-1,1-bisphosphonate |
| 4988K7X26P |
| A805927 |
| AB10152 |
| AC1Q1W16 |
| AHBuBP |
| AHButBP |
| AKOS015895071 |
| Alend |
| ALENDRONATE SODIUM |
| Alendronate sodium anhydrous |
| Alendronate, Sodium, Trihydrate |
| Alendronic Acid Monosodium Salt |
| Alendronic acid sodium salt |
| Alendronic acid, Sodium aldendronate |
| Almerol |
| AN-32438 |
| API0001401 |
| Avalent |
| BB_SC-02791 |
| BG0020 |
| Bonalon |
| C4H12NNaO7P2 |
| CAKRAHQRJGUPIG-UHFFFAOYSA-M |
| CCG-220631 |
| CHEMBL675 |
| EX-101 |
| Fosamac |
| Fosamax |
| G-704650 |
| GTH-42 |
| GTH-42J |
| GTH-42V |
| GTH-42W |
| HMS3604I12 |
| HMS3713P04 |
| Hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate (Na+) |
| I06-0478 |
| Indrol |
| J-005667 |
| KS-1028 |
| L-670452 |
| LS-106423 |
| MER-103 |
| MFCD00868112 |
| MK 217 |
| MK-0217 |
| MK-217 |
| Monosodium (4-Amino-1-hydroxy-1-phosphonobutyl)phosphonate |
| Monosodium alendronate |
| NeoBon |
| Onclast |
| Osteovan |
| P,P'-(4-Amino-1-hydroxybutylidene)bis-phosphonic acid monosodium salt |
| Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-, monosodium salt |
| SC-22170 |
| SCHEMBL328770 |
| sodium (4-amino-1-hydroxy-1-phosphono-butyl)-hydroxy-phosphinate |
| sodium (4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate |
| sodium (4-azanyl-1-oxidanyl-1-phosphono-butyl)-oxidanyl-phosphinate |
| Sodium alendronate |
| sodium alendronate(1-) |
| sodium hydrogen-4-amino-1-hydroxy-1-phosphonobutylphosphonate |
| sodium hydrogen(4-amino-1-hydroxy-1-phosphonobutyl)phosphonate |
| Steovess |
| Teiroc |
| UNII-4988K7X26P |
| Y-8756 |
US Patents and Regulatory Information for BINOSTO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Mission Pharma | BINOSTO | alendronate sodium | TABLET, EFFERVESCENT;ORAL | 202344-001 | Mar 12, 2012 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for BINOSTO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2004035004 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 03075884 | ➤ Sign Up |
| European Patent Office | 2277503 | ➤ Sign Up |
| Spain | 2380924 | ➤ Sign Up |
| Denmark | 1490024 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for BINOSTO
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1175904 | 2007C/048 | Belgium | ➤ Sign Up | PRODUCT NAME: ALENDRONATE DE SODIUM/COLECALCIFEROL; AUTHORISATION NUMBER AND DATE: EU/1/05/310/001 20050826 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
